123 related articles for article (PubMed ID: 37758066)
1. PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma.
Fontana F; Macchi C; Anselmi M; Rizzuto AS; Ruscica M; Limonta P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166897. PubMed ID: 37758066
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
4. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.
Marzagalli M; Moretti RM; Messi E; Marelli MM; Fontana F; Anastasia A; Bani MR; Beretta G; Limonta P
Sci Rep; 2018 Jan; 8(1):587. PubMed ID: 29330434
[TBL] [Abstract][Full Text] [Related]
5. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
[TBL] [Abstract][Full Text] [Related]
6. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy.
Praharaj PP; Panigrahi DP; Bhol CS; Patra S; Mishra SR; Mahapatra KK; Behera BP; Singh A; Patil S; Bhutia SK
Cancer Lett; 2021 Feb; 498():217-228. PubMed ID: 33186655
[TBL] [Abstract][Full Text] [Related]
8. Lipid Storage and Autophagy in Melanoma Cancer Cells.
Giampietri C; Petrungaro S; Cordella M; Tabolacci C; Tomaipitinca L; Facchiano A; Eramo A; Filippini A; Facchiano F; Ziparo E
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617309
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
Fiorillo M; Tóth F; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Alcalá S; Villarino L; Ruiz-Cañas L; Couceiro JR; Martínez-Calvo M; Palencia-Campos A; Navarro D; Cabezas-Sainz P; Rodriguez-Arabaolaza I; Cordero-Barreal A; Trilla-Fuertes L; Rubiolo JA; Batres-Ramos S; Vallespinos M; González-Páramos C; Rodríguez J; Gámez-Pozo A; Vara JÁF; Fernández SF; Berlinches AB; Moreno-Mata N; Redondo AMT; Carrato A; Hermann PC; Sánchez L; Torrente S; Fernández-Moreno MÁ; Mascareñas JL; Sainz B
J Exp Clin Cancer Res; 2024 Jan; 43(1):33. PubMed ID: 38281027
[TBL] [Abstract][Full Text] [Related]
11. Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells.
Monji K; Uchiumi T; Hoshizawa S; Yagi M; Matsumoto T; Setoyama D; Matsushima Y; Gotoh K; Amamoto R; Kang D
Oncotarget; 2016 Nov; 7(46):75221-75234. PubMed ID: 27655692
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.
Kulesza DW; Przanowski P; Kaminska B
Cell Biol Int; 2019 Jun; 43(6):613-622. PubMed ID: 30958597
[TBL] [Abstract][Full Text] [Related]
13. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
Chandrasekaran S; DeLouise LA
Biomaterials; 2011 Dec; 32(35):9316-27. PubMed ID: 21917310
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
15. Chelerythrine Chloride Inhibits Stemness of Melanoma Cancer Stem-Like Cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction.
Li H; He M; Zhao P; Liu P; Chen W; Xu X
Comput Math Methods Med; 2022; 2022():4000733. PubMed ID: 35761835
[TBL] [Abstract][Full Text] [Related]
16. TGFβ-dependent mitochondrial biogenesis is activated during definitive endoderm differentiation.
Li S; Huang Q; Mao J; Li Q
In Vitro Cell Dev Biol Anim; 2020 May; 56(5):378-385. PubMed ID: 32514718
[TBL] [Abstract][Full Text] [Related]
17. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
18. Ubiquilin 1 suppresses the cancer stem cell-like traits of non-small cell lung cancer cells by regulating reactive oxygen species homeostasis.
Liu T; Ma Q; Li W; Hu Y; Yang J; Yao Q
Bioengineered; 2021 Dec; 12(1):7143-7155. PubMed ID: 34546848
[TBL] [Abstract][Full Text] [Related]
19. Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.
Sztiller-Sikorska M; Koprowska K; Jakubowska J; Zalesna I; Stasiak M; Duechler M; Czyz ME
Melanoma Res; 2012 Jun; 22(3):215-24. PubMed ID: 22495670
[TBL] [Abstract][Full Text] [Related]
20. Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.
Ostyn P; El Machhour R; Begard S; Kotecki N; Vandomme J; Flamenco P; Segard P; Masselot B; Formstecher P; Touil Y; Polakowska R
Cell Commun Signal; 2014 Sep; 12():52. PubMed ID: 25223735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
